Baseline Epigenetics as a Biomarker of Mepolizumab Response in Severe Asthma. Zhang H, Jin X, Arshad H, Kurukulaaratchy RJ, et al. Clin Exp Allergy 2025 Dec 12. doi: 10.1111/cea.70195.

Read + Share

Amedeo Smart

Independent Medical Education

Zhang H, Jin X, Arshad H, Kurukulaaratchy RJ, et al. Baseline Epigenetics as a Biomarker of Mepolizumab Response in Severe Asthma. Clin Exp Allergy 2025 Dec 12. doi: 10.1111/cea.70195.
PMID: 41387235